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Background: Allergen uptake by DCs is central to allergic sensitization.
Results: DC-SIGN recognizes major allergens from house dust mite and dog. However, silencing DC-SIGN leads to Th2
differentiation.
Conclusion: DC-SIGN is a newly identified receptor for Der p 1 and Can f 1 that appears to support Th1 cell differentiation.
Significance: Understanding of how allergic responses are selected and propagated is essential for developing novel therapies.
Dendritic cells (DCs) have been shown to play a key role in the
initiation and maintenance of immune responses to microbial
pathogens as well as to allergens, but the exact mechanisms of
their involvement in allergic responses and Th2 cell differenti-
ation have remained elusive. Using retagging, we identified DC-
SIGN as a novel receptor involved in the initial recognition and
uptake of the major house dust mite and dog allergens Der p 1
andCan f 1, respectively. To confirm this,weused gene silencing
to specifically inhibit DC-SIGN expression by DCs followed by
allergen uptake studies. Binding and uptake of Der p 1 and Can
f 1 allergens was assessed by ELISA and flow cytometry. Intrigu-
ingly, our data showed that silencing DC-SIGN on DCs pro-
motes a Th2 phenotype inDC/T cell co-cultures. These findings
should lead to better understanding of the molecular basis of
allergen-inducedTh2 cell polarization and in doing so paves the
way for the rational design of novel intervention strategies by
targeting allergen receptors on innate immune cells or their car-
bohydrate counterstructures on allergens.
Dendritic cells (DCs)4 act as sentinels of the immune system
and serve as a bridge between innate and adaptive immunity.
Internalization of antigens by DCs is an important step in the
sequence of events that leads to the induction of the adaptive
immune response (1). DCs can efficiently sample their
microenvironment using a plethora of receptors such as C-type
lectin receptors (CLRs), Toll-like receptors, or scavenger recep-
tors (2). Immature DCs take up antigens in peripheral tissues,
process them into peptides, and then migrate to lymph nodes
where they acquire a fully mature status capable of stimulating
naïve T cells (3, 4). Immature DCs are characterized by their
superior capacity for antigen uptake which can be attributed to
the numerous CLRs that are highly expressed on these cells.
These CLRs includemannose receptor (MR, CD206), dendritic
cell-specific intracellular adhesion molecule (ICAM)-3-grab-
bing non-integrin (DC-SIGN, CD209), and dendritic and epi-
thelial cells, 205 kDa (DEC-205, CD205) (5–7). C-type lectins
are calcium-dependent carbohydrate-binding glycoproteins
with a wide range of biological functions characterized by the
presence of at least one carbohydrate recognition domain that
interactswith and recognizes carbohydrates via eithermannose
or galactose side chains (8–11).
DCs have been shown to play a key role in the initiation and
maintenance of immune responses to microbial pathogens as
well as to allergens, but the exact mechanisms of their involve-
ment in allergic responses and Th2 cell differentiation have
remained elusive (12, 13). Given the importance of antigen rec-
ognition and uptake byDCs on downstream events leading to T
cell differentiation, there is considerable interest in identifying
potential receptors for allergens on DCs. Within this context,
we and others have shown that MR is partially involved in the
uptake of Der p 1, the major allergen from house dust mite (14,
15). Blocking MR by mannan (14) or its down-regulation using
siRNA (15) leads to approximately 60–70% reduction in Der p
1 uptake by human monocyte-derived DCs. The residual
uptake after blocking MR does not seem to be due to macropi-
nocytosis by DCs, and as such it is reasonable to suggest the
presence of other putative allergen receptors on DCs. In this
study, using a number of different approaches including confo-
cal microscopy, receptor activity-directed affinity tagging
(retagging) (16, 17) and gene silencing, we show that Der p 1
and Can f 1 uptake by human DCs is also mediated by DC-
SIGN. Although down-regulation of MR inhibits Th2 differen-
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tiation (15, 18), intriguinglywe have shown that knocking down
DC-SIGN expression on humanDCs leads to a bias towardTh2
cell differentiation in autologous DC-T cell co-cultures, sug-
gesting an antagonistic relationship between the two main
allergen receptors expressed on DC surface.
Early events at the interface of allergens and DCs play a key
role in downstream events leading to allergic sensitization.
Therefore, identifying receptors that are involved in the initial
recognition and uptake of allergens by DCs would not only lead
to better understanding of the molecular basis of allergen-in-
duced Th2 cell polarization but also pave the way for the ratio-
nal design of novel intervention strategies.
EXPERIMENTAL PROCEDURES
Cell Preparation—Immature DCs were generated from
monocytes isolated from peripheral blood of nonatopic healthy
donors (obtained with consent and after ethical committee
approval) in the presence of interleukin (IL)-4 and granulocyte-
macrophage colony-stimulating factor (GM-CSF) (250
units/ml and 50 ng/ml, respectively) (R&D Systems) in RPMI
1640 medium (Sigma-Aldrich) supplemented with 100
units/ml penicillin, 100mg/ml streptomycin, 2mM L-glutamine
(all from Sigma-Aldrich), and 10% low endotoxin FCS (Auto-
gen Bioclear, Calne, UK) for 6 days as described before (19). In
some experiments, we used NIH-3T3 fibroblast transfectants
stably expressing DC-SIGN (3T3/DC-SIGN) (a kind gift from
Dr. Vineet KewalRamani, National Cancer Institute, Bethesda,
MD) (20) and mock fibroblast cells lacking DC-SIGN.
Confocal Microscopy—To promote the adherence of DCs,
glass base dishes (IWAKI, Asahi Techno Glass Corp., Japan)
with an internal core diameter of 1 cm were coated with 6
g/ml (w/v) of poly-L-lysine (Sigma) overnight. To deplete the
cell membrane from cholesterol, immature DCs were treated
with 10mM (2-hydroxypropyl)--cyclodextrin (Sigma)which is
a more water-soluble/toxicologically benign alternative to -,
-, and -cyclodextrin (21–24). 5 105/200l -cyclodextrin-
treated or untreated DCs were then seeded in each dish for 1 h
at 37 °C, 5% CO2. Dishes were then placed under a Zeiss confo-
cal microscope (LSM501uv META combi, Welwyn Garden
City, UK) (equipped with a hot plate and tissue culture cham-
ber) and received 5 g/ml Cy5-labeled Der p 1. For each con-
dition, confocal images were taken after 20 min.
Retagging Technique—Der p 1-binding proteins were puri-
fied as described previously for the Helicobacter pylori SabA
adhesin (16, 17) with somemodifications. Briefly, Der p 1, con-
jugated to the Sulfo-SBEDmultifunctional cross-linker (Pierce,
Thermo Scientific), was incubated with DCs or monocytes
according to the manufacturer’s recommendations. The pho-
toreactive cross-linker groupwas activated by 2min of UV irra-
diation, and the biotin-(re)tagged proteins were purified with
streptavidin-coated magnetic beads.
Mass Spectrometry Analysis—Extracted biotin-tagged pro-
teins were separated by SDS-PAGE, and bands were digested
with sequencing-grade trypsin (Promega) as described previ-
ously (19) and analyzed using aMicromass ToF-Spec E (Micro-
mass). Briefly, the nanoflow LC-tandem MS was done on a
7-Tesla linear trap quadrupole-Fourier transform mass spec-
trometer (Thermo Electron) equipped with a nanospray source
modified in-house. The spectrometer was operated in data-de-
pendent mode, automatically switching to tandem MS mode.
MS spectra were acquired in the FTICR, whereas tandem MS
spectra were acquired in the linear trap quadrupole trap. For
each scan of FTICR, the three most intense, doubly or triply
charged, ions were sequentially fragmented in the linear trap by
collision-induced dissociation. All the tandem mass spectra
were searched using MASCOT PMF data base search engine
(Matrix Science, London, UK) or Aldente (expasy site) against
the databases (Sprot 54.0) for the human proteins as appropri-
ate. Search parameters included a peptide mass accuracy toler-
ance of 0.2Da and allowed for modifications such as alkylation
of cysteine during the tryptic digest procedure and the possible
formation of methionine sulfoxide (19).
Binding of Natural Allergens to Soluble DC-SIGN by ELISA—
ELISA-based binding assays were used to determine soluble
DC-SIGN (sDC-SIGN; R&D Systems) binding to different
allergens. All washing steps were performed in lectin buffer
consisting of 10 mM Tris-HCl, pH 7.5, 10 mM CaCl2, 0.154 M
NaCl, and 0.05% (w/v) Tween 20. Maxisorp plates (Nunc,
Thermo Scientific) were coated overnight with different test
allergens ormannan (5g/ml) and blockedwith 1%BSA. Plates
were sequentially incubated with 5 g/ml of sDC-SIGN and 5
g/ml DC-SIGN mAb (clone 120507; R&D Systems). Bound
antibodies were detected by incubation with phosphatase-con-
jugated goat anti-mouse Ab diluted to 1/1000, and p-nitrophe-
nyl phosphate solution (Sigma) was added to the plates at con-
centration of 1 mg/ml. Absorbance was measured at 405 nm
(Expert Plus, SLS; Nottingham, UK).
Binding of Der p 1 to NIH-3T3 Cells Expressing DC-SIGN—
Allergens were labeled with Cy3 or Cy5 (GE Healthcare) label-
ing kits according to the manufacturer’s instructions and as
described before (15). Binding assays were conducted in pres-
ence and absence of EDTA. 3T3/DC-SIGN fibroblasts were
used to study binding of Der p 1 to DC-SIGN. Briefly, cells (2
105/100 l) were incubated with Cy5 only or Cy5 Der p 1 at
37 °C for 45 min; cells were then washed and fixed in 0.5%
formaldehyde. To investigate DC-SIGN specificity, NIH-3T3
fibroblasts that lack DC-SIGN expression (mock cells) were
used, and binding was detected by flow cytometry on an Altra
flow cytometer (Beckman Coulter).
Blocking Experiments—Immature DCs were resuspended in
uptake medium (RPMI 1640 medium  30% PBS with Ca2
andMg2 10%FBS) and preincubatedwith (200g/ml)man-
nan (Sigma), or different concentrations (10 and 20 g/ml) of
Lewis-x (PAA-Lewis-x; Lectinity, Moscow, Russia) for 30 min
at 37 °C and subsequently incubated with 5 g/ml Cy5 Der p 1
for another 30 min. In some experiments, Cy5 Der p 1 was
preincubatedwith varying concentrations (5, 10, and 20g/ml)
of sDC-SIGN prior to addition to cells. BSA was used as a con-
trol. Cells were then washed and fixed in 0.5% formaldehyde,
and Der p 1 uptake was determined by flow cytometry. Results
are expressed as median fluorescence intensity (MFI).
RNA Interference—RNA interference (RNAi) was performed
by transfecting DCs with small interfering RNA (siRNA) (50
nM), using the Lipofectamine RNAiMax (Invitrogen), to specif-
ically knock down DC-SIGN. For DC-SIGN mediated gene
silencing, the following oligonucleotides were employed:
DC-SIGN Recognizes Dust Mite Allergen
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(GGCAAUGGCUGGAACGACGACAAAU), and (AUUUGU-
CGUCGUUCCAGCCAUUGCC) (Invitrogen) and the nonsi-
lencing control (CT) siRNA used was all star negative control
(Qiagen). Gene knockdown was estimated quantitatively at
message level by quantitative real time PCR (qRT-PCR) and at
protein level by flow cytometry and Western blotting.
Real Time PCR—Real time PCRs were conducted using a
MX3005P thermal cycler (Stratagene, Agilent Technologies),
and PCR amplifications were performed with the SYBR Green
method using the following primers: CD209 (forward, 5-CC-
AAAGGAGGAGACAAGCAG-3 and reverse, 5-GGACGA-
CAGCTTCAGTGTGA-3) and GAPDH (forward, 5-GAGT-
CAACGGATTTGGTCGT-3 and reverse, 5-GACAAGCTT-
CCCGTTCTCAG-3). Each reaction was performed in a final
volume of 25 l comprising 5 l of template (cDNA), 12.5 l of
SYBR Green master mix (Stratagene), 1 l (200 nm) of each
primer, and 0.38 l of ROX dye. Amplifications were per-
formed starting with an initial denaturation step of 95 °C/30 s,
followed by 40 cycles of 95 °C/30 s,56 °C/60 s, and 72 °C/60 s.
Western Blotting—DC-SIGN knockdown was assessed by
Western blotting as described elsewhere (25). Briefly, proteins
were run on SDS-PAGE, transferred to nitrocellulose mem-
branes (Amersham Biosciences, GE Healthcare), blocked with
(PBS  0.05% Tween 20  5% milk), and subsequently probed
with rabbit polyclonal Ab to human CD209 (2 g/ml; AbD
Serotec, Kidlington, UK) ormouse anti-humanmAb to -actin
(Sigma). Membranes were washed and reprobed with HRP-
conjugated goat anti-rabbit IgG (Fc) or rabbit F(ab)2 anti-
mouse IgG:HRP (AbD Serotec). Bands were visualized with
ECL reagent (AmershamBiosciences), and the intensity of each
protein was normalized against -actin as an internal loading
control. In retagging experiments the blots were probed with
streptavidin directly conjugated with HRP (1:5000 dilution)
(Thermo Fischer Scientific).
Effect of DC-SIGNKnockdown onDer p 1 andCan f 1Uptake—
DCs were transfected at day 1, and the effect of DC-SIGN gene
silencing on uptake was studied. Briefly, DCs that have previ-
ously been treated with CT orDC-SIGN siRNAwere washed in
PBS, resuspended in uptake medium, and incubated with 5
g/ml of eitherCy5Der p 1 orCy3Can f 1 for 30min.Cellswere
then washed and fixed in 0.5% formaldehyde, and the quantita-
tive uptake of Cy5 Der p 1 and Cy3 Can f 1 was then estimated
by flow cytometry.
Effect of DC-SIGN Down-regulation on T Cell Polarization—
Naïve (CD3/CD45RA) T cells were isolated by immuno-
magnetic cell sorting (Miltenyi Biotec) according to the manu-
facturer’s instructions. DCs that had previously been treated
with either CT or CD209 siRNAwere loaded or not for 6 h with
5 g/ml natural Der p 1 (Indoor Biotechnologies, Wiltshire,
UK).DCswerewashed and cultured in 96-well U-bottomplates
(Nunc) with CD3CD45RA autologous T cells (ratio DC/T
cell: 1/5) in RPMI 1640 medium plus 5% human AB serum
(Sigma). On day 3, rh-IL-2 (20 units/ml; R&D Systems) was
added to the cells, and feeding with fresh medium and IL-2 was
performed every 3–4 days. After 16 days, T cells were restimu-
lated for 8 h with autologous DCs (ratio DC/T cell: 1/1) loaded
or not with Der p 1. For intracellular staining, brefeldin A (10
g/ml; Sigma) was added for the last 6 h, and the production of
IL-4 and interferon (IFN)- was detected on CD4 cells by
intracellular staining (26) using anti-IL-4-PE (clone 4D9) and
anti-IFN--FITC (clone 45.15); both were purchased from
Beckman Coulter.
Statistical Analysis—Statistical analyses were performed by
using GraphPad Prism 4.0 (GraphPad Software, San Diego,
CA). Student’s t tests or theMann-WhitneyU test was used for
pairwise comparisons analysis. One-way ANOVAwith Bonfer-
roni’s post hoc test was used for multiple comparisons analysis.
Significance was accepted when p values  0.05, where *, p 
0.05; **, p 0.01; ***, p 0.001. Data were expressed asmean
S.E.
RESULTS
Glycoallergen Uptake by HumanDCs Is a Receptor-mediated
Event—Using cyclodextran (27), we depleted the DC mem-
brane from cholesterol thereby disrupting all receptor-medi-
ated endocytosis (28). This led to almost complete abrogation
ofDer p 1 uptake byDCs comparedwith control cultureswhich
were not treated by cyclodextran (Fig. 1). We did not observe
any changes in DC viability upon cyclodextran treatment (data
not shown). This observation together with our previous data
(15) showing thatMR is only responsible for 60–70% of Der p 1
uptake by human DCs clearly suggest the presence of other
putative receptors on DCs that are capable of allergen uptake.
DC-SIGN Is Novel Receptor forMajor House DustMite Aller-
gen Der p 1—To identify other receptors on human DCs that
are involved in Der p 1 uptake, we used retagging, a powerful
tool for identifying cell surface receptors (16, 17). Using this
technique, we were able to identify DC-SIGN as a novel recep-
tor for Der p 1 (Fig. 2). Subsequently, the functional importance
and contribution of DC-SIGN to uptake of allergens were
assessed using a number of complementary approaches. First,
we investigated the binding of DC-SIGN to different allergens
using ELISA. Der p 1 (OD values  1.416  0.078), Can f 1
(1.153  0.043), and Ara h 1 (OD  0.930  0.003), which was
previously identified asDC-SIGN ligands (29), were all found to
bind to DC-SIGN, albeit with different strengths, whereas the
cat allergen Fel d 1 did not show any binding (Fig. 3).
A more physiologically relevant approach to study the bind-
ing of Der p 1 to DC-SIGN involved NIH-3T3 fibroblast trans-
fectants stably expressing DC-SIGN. This showed that Cy5-
labeled Der p 1 binds to NIH-3T3 fibroblasts expressing
DC-SIGN (Fig. 4) but notmock cells as detected by flow cytom-
FIGURE 1. Confocal microscopy showing the uptake of Cy5 Der p 1 by DCs
before and after treatment with -cyclodextrin. The uptake of Cy5-labeled
Der p 1 by DC before (A) and after (B) treatment with 10 mM (2-hydroxypro-
pyl)--cyclodextrin for 1 h is shown. The loss of Der p 1 localization (hot spots)
after depletion of cholesterol from cell membrane is indicative of the involve-
ment of membrane rafts (i.e. a receptor-ligand interaction).
DC-SIGN Recognizes Dust Mite Allergen
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etry. Incubation with EDTA completely abrogated the binding,
indicating that binding is Ca2-dependent.
Furthermore, based on the carbohydrate specificity of Lew-
is-x forDC-SIGN (30, 31), we sought to blockDC-SIGNonDCs
using Lewis-x antigen to investigate further the impact of DC-
SIGN on Der p 1 uptake by DCs. This resulted in a reduction of
Der p 1 uptake by DCs. Results obtained (Fig. 5A) demonstrate
that Der p 1 uptake was inhibited by Lewis-x in a dose-depen-
dent manner with blocking reaching a plateau at 20g/ml (p
0.05, n  3). Mannan was used as a control and inhibited Der p
1 uptake by 60% which was in line with previous observations
(14, 15).
Preincubation of Der p 1 with Soluble DC-SIGN Reduces Der
p 1Uptake byDCs inDose-dependentManner—Wealso sought
to study the interaction between Der p 1 and DC-SIGN by flow
cytometry through preincubation of Der p 1with different con-
centration of sDC-SIGN. This resulted in a dose-dependent
and statistically significant decrease inDer p 1 uptake (p 0.05,
n  3) further confirming the role of DC-SIGN in recognition
of Der p 1 (Fig. 5B). Similar concentrations of BSA did not lead
to any changes in Der p 1 uptake (data not shown).
DC-SIGN Down-regulation Reduces Der p 1 and Can f 1
Uptake byDCs—Toevaluate further the role ofDC-SIGN in the
uptake of Der p 1 and Can f 1 by DCs, we investigated the
impact of DC-SIGN down-regulation following siRNA experi-
ments. Here, we describe an efficient siRNA strategy for the
systematic knockdown ofDC-SIGNon human cells, as a simple
and highly reproducible method. The quantitative measure-
ment of gene silencing at the mRNA and protein levels was
achieved via qRT-PCR (Fig. 6A), flow cytometry (Fig. 6, B and
C), and Western blotting (Fig. 6D), obtaining percentage inhi-
bition of 70–80%. In line with our previous studies (15, 32), DC
viability after siRNA treatment as well as the expression and
localization of MR was not affected by silencing DC-SIGN
expression (data not shown). Allergen uptake data obtained
following specific DC-SIGN gene silencing demonstrated a sig-
nificant reduction in Der p 1 (32%; p  0.01, n  9) and Can f 1
(33%; (p  0.01, n  4) uptake by DCs (Fig. 7). No effect was
observed in the uptake of the negative control, FITC-SO4-3-
galactose, a specific ligand that is taken up by MR, confirming
FIGURE 2. Identification of DC-SIGN as a novel receptor for Der p 1 on DCs
by retagging technique. Der p 1, conjugated with Sulfo-SBED multifunc-
tional cross-linker, was incubated with DCs or monocytes. After photoreac-
tive cross-linking, the biotin-(re)tagged proteins were purified with streptavi-
din-coated magnetic beads. Extracted biotin-tagged proteins were
separated by SDS-PAGE. Western blotting analysis revealed a band at 44 kDa
in DC condition (lane 1) corresponding to DC-SIGN. No bands were obtained
in the case of monocytes (lane 2). Mannose receptor (MR, 180 kDa), which has
previously been identified as Der p 1 receptor on DCs, was also obtained in
the retagging experiments.
FIGURE 3. Detection of natural allergen binding to sDC-SIGN by ELISA.
ELISA plates were coated overnight with Der p 1, Can f 1, Ara h 1, Fel d 1, or
mannan. Binding to sDC-SIGN was investigated using DC-SIGN mAb (clone
120507). Der p 1, Can f 1, and Ara h 1 were found to bind sDC-SIGN with
referral to mannan as a control, whereas no binding was detected with Fel d 1.
Data presented are the average of four independent experiments  S.E. (error
bars). ***, p  0.001.
FIGURE 4. Binding of Der p 1 to NIH-3T3 cells expressing DC-SIGN. Cells
(2  105/100 l) were incubated with Cy5 Der p 1 or Cy5 alone, and binding
was determined by flow cytometry. Results obtained demonstrate that Der p
1 binds to NIH-3T3 fibroblasts expressing DC-SIGN. A–D, dot plots corre-
sponding to cells only (A), cells incubated with Cy5 only (B), cells incubated
with Cy5 Der p 1 (C), cells treated with EDTA (D). E, histogram demonstrating
Der p 1 binding to NIH-3T3 cells expressing DC-SIGN.
DC-SIGN Recognizes Dust Mite Allergen
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that the reduction in uptake obtained following siRNA treat-
ment was DC-SIGN-mediated.
DC-SIGN Down-regulation Favors Th2 Cell Polarization in
DC-T Cell Co-cultures—DCs that have previously been treated
with either CT or DC-SIGN siRNA were loaded or not for 6 h
with 5 g/ml natural Der p 1 and cultured with CD3/
CD45RA autologous T cells for up to 16 days. After restimu-
lation with autologous DCs, the percentages of IL-4 and IFN-
producing T cells were determined by intracellular staining.
Given that the cells were isolated from peripheral blood of a
nonatopic donor, not surprisingly both in the presence and
absence of Der p 1 stimulation of naïve T cells by DC-SIGN-
expressing DCs (CT-DCs) there was a Th1 bias as evidenced by
high levels of IFN- production (Fig. 8). This is in line with
previous observations showing that in healthy donors, the pres-
ence of natural Der p 1 dramatically enhanced Th1 polarization
(33, 34). By contrast, our data show that silencing of DC-SIGN
expression dampened the Th1 polarization in the unloaded as
well as in the Der p 1 loaded condition mainly through a signif-
icant increase in IL-4 secretion as well as slight decrease in
IFN- production. Interestingly, with the DC-SIGN-deficient
cells, loading with Der p 1 resulted in a further reduction of the
Th1 skewing.
DISCUSSION
We have previously shown that the uptake of a number of
glycoallergens such as Der p 1 is mediated through MR; how-
ever,MR seems to be responsible for only approximately 60% of
this uptake (15). Previous work (14) suggested that the residual
Der p 1 uptake does not seem to bemediated throughmacropi-
nocytosis, which is in line with our own observations (data not
shown). Almost all endocytic pathways are sensitive to choles-
terol perturbation (28), and clathrin-dependent (35) and -inde-
pendent pathways (36) are both inhibited by the removal of
cholesterol. In this study, using cyclodextran (27), we depleted
the DC membrane from cholesterol thereby disrupting all
receptor-mediated endocytosis (28). This led to almost com-
plete abrogation of Der p 1 uptake by DCs compared with con-
trol cultures which were not treated by cyclodextran. These
data clearly suggest the presence of other putative receptors on
DCs that are capable of allergen uptake.
To identify such receptorsweused retagging,which ismainly
based on labeling the protein of interest with a multifunctional
cross-linker composed of a biotin tag disulfide bonded to a pho-
toreactive group. Thus, allowing the labeled allergen to interact
with the cells and then subjecting the cells toUV irradiationwill
enable the photoreactive group to form a covalent bond with
FIGURE 5. Lewis-x and sDC-SIGN reduce Der p 1 uptake by DCs. DCs were
incubated with Cy5 Der p 1 previously preincubated or not with increasing
concentrations of Lewis-x (10 and 20 g/ml) (A) or sDC-SIGN (5, 10, and 20
g/ml) (B). Mannan (200 g/ml) was used as a control. Quantitative Cy5 Der p
1 uptake by DCs was estimated by flow cytometry. Dose-dependent inhibi-
tion of Der p 1 uptake was obtained. Result shown represents three inde-
pendent experiments expressed as average median fluorescence intensity
(MFI)  S.E. (error bars). FIGURE 6. Estimation of DC-SIGN gene silencing by various techniques. A,
DCs were transfected at day 1, and down-regulation of DC-SIGN expression
was quantitatively analyzed at message level by qRT-PCR. Transcription of
mRNA was inhibited by 73% (n  6) after normalization against GAPDH. B,
flow cytometric analysis of DC-SIGN silencing showed that siRNA treatment
of DCs inhibits DC-SIGN surface expression by 80% compared with cells
treated with CT siRNA. C, dot plot corresponds to cells treated with CT or
DC-SIGN siRNA. D, assessment of DC-SIGN knockdown by Western blotting
shows that DC-SIGN expression was inhibited by 82% with referral to -actin
as a reference internal control. ***, p  0.001. Error bars indicate S.E.
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structures in the immediate vicinity. The bound receptor could
then be extracted and identified by mass spectroscopy (16, 17).
Using this technique, we identified DC-SIGN as a novel recep-
tor for themajor house dustmite and dog allergens, Der p 1 and
Can f 1, respectively.
Having identified DC-SIGN as a potential receptor for Der p
1 on DCs, we set out to investigate its role in Der p 1 uptake by
DCs. The functional importance and contribution of DC-SIGN
to Der p 1 uptake by human DCs were assessed using different,
but complementary approaches. First, we investigated the
binding ofDC-SIGN todifferent allergens using ELISA.Der p 1,
Can f 1, and Ara h 1 were all found to bind to DC-SIGN in
contrast to the cat allergen Fel d 1 which showed no binding.
Another, perhaps more physiologically relevant, approach is to
study the binding of Der p 1 to DC-SIGN using 3T3/DC-SIGN
cells (20, 37). This showed that Cy5 Der p 1 binds to 3T3 fibro-
blasts expressing DC-SIGN, but not to mock cells as detected
by flow cytometry. Incubation with EDTA completely abro-
gated the binding, indicating that binding is Ca2-dependent.
The above binding data prompted us to investigate whether
DC-SIGN is involved in allergen uptake by human DCs. Based
on the carbohydrate specificity of Lewis-x for DC-SIGN (30,
31), we therefore sought to target DC-SIGN on DCs using a
natural ligand (Lewis-x antigen) to investigate further the
impact of DC-SIGN engagement on Der p 1 uptake by DCs.
Results obtained demonstrated dose-dependent and significant
inhibition of Der p 1 uptake by Lewis-x with nearly 20% inhibi-
tion with highest concentration (20 mg/ml) of Lewis-x.
DC-SIGN has also been shown to mediate the uptake of var-
ious allergens such as the major peanut allergen (Ara h 1) (29),
as well as the Bermuda grass pollen allergen (BG-60) and the
major group 2 allergen from house dust mite (Der p 2) (38). As
such, this and other reports clearly underscore the potential of
CLRs (in particular MR and DC-SIGN), which are highly
expressed on the surface of antigen-presenting cells, to serve as
common receptors for recognition of a wide range of glycosy-
lated allergens. Intriguingly, we have also shown for the first
time that down-regulation of DC-SIGN expression through
siRNA leads to a bias toward Th2 polarization in autologous
DC-T cell co-cultures. This is in contrast with our earlier work
showing that down-regulation of MR, a major Der p 1 receptor
expressed on DCs, leads to an opposite effect, i.e. bias toward
Th1 polarization (15, 18). This could be partly explained by data
showing that differentiation of naive T cells toward Th2 occurs
upon co-stimulation through ICAM-1 and ICAM-2 instead of
ICAM-3, which is thought to be the main DC-SIGN counter-
structure on T cells (39).Within this context, it is interesting to
note that we have shown previously (37) that Der p 1, a cysteine
protease, in its enzymatically active form, can cleave DC-SIGN
(its “Th1-promoting” receptor) but not MR (its “Th2-promot-
ing” receptor), and this will further amplify its alleregenicity.
Although the exact mechanism of polarized Th2 cell differen-
tiation in the absence ofDC-SIGN is yet to be determined, these
data clearly indicate that glycoallergen uptake by DCs and
events leading to downstream Th2 polarization are complex
FIGURE 7. Der p 1 and Can f 1 uptake by CT or DC-SIGN-deficient DCs. DCs
were transfected at day 1 with CT siRNA or DC-SIGN siRNA, and the impact of
DC-SIGN knockdown on uptake was assessed at day 6. Cells that were treated
with DC-SIGN siRNA showed a 32% reduction in Der p 1 uptake (n  9) and
33% reduction in Can f 1 uptake (n  4) compared with cells treated with CT
siRNA. No effect on sulfated sugar was noticed after DC-SIGN gene silencing.
Data are presented as average median fluorescence intensity (MFI)  S.E.
(error bars).
FIGURE 8. T cell polarization after DC-SIGN knockdown. A and B, DC-SIGN
knockdown on DCs skews Th1/Th2 toward Th2. DCs (CT and DC-SIGN-defi-
cient) from four different donors were preloaded or not with Der p 1 prior to
establishing autologous DC-T cell co-cultures with naïve (CD3/CD45RA) T
cells. On day 16, T cells were restimulated for 8 h with Der p 1-loaded or
-unloaded DCs (not treated with siRNA), and IFN- (A) and IL-4 (B) production
was analyzed by intracellular staining (n  4). C, as an indicator of polariza-
tion, the ratio of IFN- to IL-4 based on the data obtained in A and B was
calculated. *, p  0.05.
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and involve at least two receptors, MR and DC-SIGN, whose
engagement by allergen leads to distinct and possibly antago-
nistic signaling events. Therefore, it is reasonable to assume
that the overall fate of T cells in response to allergen exposure in
different individuals could at least be partly determined by dif-
ferential level of MR and DC-SIGN expression on DC subsets.
In this connection, it is interesting to note that MR expression
has been shown to be higher in atopic individuals (14).
Early events at the interface of DCs and allergens are clearly
of great importance in determining T cell polarization. In this
study, we have identified a novel receptor for two major aller-
gens fromhouse dustmite and dog, Der p 1 andCan f 1, respec-
tively. This new insight could lead to better understanding of
the molecular basis of allergen-induced Th2 cell polarization,
and this should hopefully pave theway for the rational design of
novel intervention strategies.
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